Latest news

Report on regional disparities presented in Rome along with MPs and top cancer stakeholders

On December 9 All.Can Italy held its last event of 2019 where it presented the report ‘Regional disparities in cancer care: evidences and actions’.

All.Can Italy: poster on regional disparities presented at ISPOR

Outcomes of the All.Can analysis on regional disparities in cancer care across Italy have been presented at ISPOR.

All.Can Switzerland initiative officially launches as a non-profit organisation

All.Can Switzerland has officially launched as a non-profit organisation with an event at the University of Zurich.

EFPIA’s 2019 Health Collaboration Guide features All.Can international

We are pleased to announce that the All.Can international has been featured in the EFPIA 2019 Health Collaboration Guide. Now in its third year, the guide showcases best practice collaborations…

Work with All.Can as its new CEO

All.Can International is currently looking to recruit a Chief Executive Officer (CEO) to lead the initiative into an exciting new phase.

All.Can at the World Summit of Brain Tumour Patient Advocates

At the 4th Biennial World Summit of Brain Tumour Patient Advocates Suzanne Wait, shared findings from the All.Can patient survey with participants, focusing on findings specific to patients with brain/central nervous system (CNS) tumours.

All.Can international welcomes nomination of new EU Commissioner for Health and Food Safety

On 2 October 2019 All.Can international sent a letter to Stella Kyriakidou welcoming her unique perspective in the field of health, and sharing key findings from the All.Can patient survey.

255 Canadian cancer patients share the most wasteful and inefficient parts of their cancer care and treatment

The Canadian All.Can cancer initiative has this month published a major report of cancer care recommendations based on patient insights following a Canada-wide patient survey conducted last year that gathered…

All.Can welcomes Roche as a new funding member

All.Can is delighted to welcome Roche as a new funding member of the international initiative.